Literature DB >> 10391865

Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects.

P Toniutto1, C Fabris, F Barbone, S G Tisminetzky, D Liani, T Galai, G Barillari, F Biffoni, V Gasparini, M Pirisi.   

Abstract

The hepatitis G virus (HGV) polyprotein was scanned by computer-aided prediction of antigenicity to search for B-cell epitopes. Four polypeptide sequences, V37D (amino acids [aa] 1685 to 1721), V36S (aa 2102 to 2137), P37R (aa 2156 to 2192), and C40P (aa 2280 to 2319), were identified and synthesized for use in immunoassays. Antibodies to these peptides were searched for in a panel of 239 serum samples, which were also tested for anti-E2 antibodies and HGV RNA. Furthermore, the course of HGV markers was studied prospectively in four patients who had been transfused with HGV RNA-positive blood. There was a negative association between immunoreactivity to V37D and P37R and presence of HGV RNA (2 of 53 and 1 of 53, respectively; P < 0.05); none of the subjects with dual antibody positivity was HGV RNA positive. Anti-V37D and anti-P37R antibodies compared favorably with anti-E2 antibodies as markers of recovery from HGV infection. These results might be useful for the development of new, more sensitive diagnostic assays.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391865      PMCID: PMC95730          DOI: 10.1128/CDLI.6.4.573-576.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients.

Authors:  S J Cotler; D R Gretch; M P Bronner; H Tateyama; M J Emond; C dela Rosa; J D Perkins; R L Carithers
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

2.  Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients.

Authors:  H H Feucht; B Zöllner; S Polywka; B Knödler; M Schröter; H Nolte; R Laufs
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

3.  Prediction of sequential antigenic regions in proteins.

Authors:  G W Welling; W J Weijer; R van der Zee; S Welling-Wester
Journal:  FEBS Lett       Date:  1985-09-02       Impact factor: 4.124

4.  High prevalence of infection with hepatitis G virus in patients with hepatic and extrahepatic malignancies.

Authors:  P Toniutto; M Pirisi; C Fabris; P Bardus; G Soardo; D Vitulli; S G Tisminetzky; P Pacco; V Gasparini; F Baralle; E Bartoli
Journal:  J Hepatol       Date:  1998-04       Impact factor: 25.083

5.  Two-stage transformation systems for normalization of reference distributions evaluated.

Authors:  K Linnet
Journal:  Clin Chem       Date:  1987-03       Impact factor: 8.327

6.  Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions.

Authors:  P Toniutto; M Pirisi; S G Tisminetzky; C Fabris; E Chinellato; M Gerotto; E Falleti; P Ferroni; T Lombardelli; E Bartoli; F Baralle
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus.

Authors:  J Petrik; L Guella; D G Wight; G M Pearson; J Hinton; H Parker; J P Allain; G J Alexander
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

8.  GB virus-C/hepatitis G virus infection in prostitutes: possible role of sexual transmission.

Authors:  J H Kao; W Chen; P J Chen; M Y Lai; R Y Lin; D S Chen
Journal:  J Med Virol       Date:  1997-08       Impact factor: 2.327

9.  Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors.

Authors:  K Stark; U Bienzle; G Hess; A M Engel; B Hegenscheid; V Schluter
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

10.  HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection.

Authors:  E Silini; L Belli; A B Alberti; M Asti; A Cerino; M Bissolati; G Rondinara; L De Carlis; D Forti; M U Mondelli; G Ideo
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

View more
  1 in total

1.  Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection.

Authors:  Leticia Fernández; M José Bleda; M José Gómara; Isabel Haro
Journal:  Anal Bioanal Chem       Date:  2012-12-13       Impact factor: 4.142

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.